Literature DB >> 1992994

Pneumonia complicating abdominal sepsis. An independent risk factor for mortality.

R A Mustard1, J M Bohnen, C Rosati, B D Schouten.   

Abstract

Nosocomial pneumonia (NP) is associated with a significant mortality, 66% in a previous retrospective study of NP complicating intra-abdominal sepsis (IAS). We prospectively compared the outcome of NP complicating IAS with that of recurrent IAS (R-IAS) in the absence of NP. Data were collected prospectively on 300 patients with IAS; 34 patients who presented with pneumonia were excluded from the analysis (44% mortality). One hundred seventy-one patients with no NP and no R-IAS (group 1) had a hospital mortality of 20% (34 patients); 36 without NP in whom R-IAS developed (group 2) had a 17% mortality (six patients); and 47 with NP but no R-IAS (group 3) had a 53% mortality (25 patients). Finally, 12 patients who had both NP and R-IAS suffered a 75% mortality (nine patients). We examined the relationships among the following putative risk factors and mortality: APACHE (acute physiology and chronic health evaluation) II score (at initial presentation with IAS), the need for mechanical ventilatory assistance following initial treatment for peritonitis, steroid requirement, generalized peritonitis vs abscess, and the need for surgical as opposed to percutaneous treatment. Using mortality as the dependent variable, group 2 vs 3 as the explanatory variable, and the risk factors as confounders, logistic regression analysis indicated that the group difference was significant after controlling for confounders. We conclude that NP complicating IAS is an independent risk factor associated with a significant mortality compared with R-IAS. These data challenge the notion that death in IAS is usually due to recurrent or persistent intra-abdominal infection.

Entities:  

Mesh:

Year:  1991        PMID: 1992994     DOI: 10.1001/archsurg.1991.01410260058008

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  8 in total

Review 1.  Sepsis-induced immunosuppression: from bad to worse.

Authors:  R C Reddy; G H Chen; P K Tekchandani; T J Standiford
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

2.  Alterations in intestinal motility and microflora in experimental acute pancreatitis.

Authors:  P Leveau; X Wang; V Soltesz; I Ihse; R Andersson
Journal:  Int J Pancreatol       Date:  1996-10

3.  Utilization of acute inpatient services for alcohol detoxification.

Authors:  B M Booth; F C Blow; R L Ludke; R L Ross
Journal:  J Ment Health Adm       Date:  1996

Review 4.  Clinical predictors of ongoing infection in secondary peritonitis: systematic review.

Authors:  Bas Lamme; Cecilia W Mahler; Oddeke van Ruler; Dirk J Gouma; Johannes B Reitsma; Marja A Boermeester
Journal:  World J Surg       Date:  2006-12       Impact factor: 3.352

5.  Period of irreversible therapeutic intervention during sepsis correlates with phase of innate immune dysfunction.

Authors:  David M Cauvi; Donghuan Song; Daniel E Vazquez; Dennis Hawisher; Jose A Bermudez; Michael R Williams; Stephen Bickler; Raul Coimbra; Antonio De Maio
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

Review 6.  Prevention and therapy of the adult respiratory distress syndrome.

Authors:  B Temmesfeld-Wollbrück; D Walmrath; F Grimminger; W Seeger
Journal:  Lung       Date:  1995       Impact factor: 2.584

7.  Therapeutic Evaluation of Computed Tomography Findings for Efficacy of Prone Ventilation in Acute Respiratory Distress Syndrome Patients with Abdominal Surgery.

Authors:  Masayuki Akatsuka; Hiroomi Tatsumi; Naoya Yama; Yoshiki Masuda
Journal:  J Crit Care Med (Targu Mures)       Date:  2020-01-31

8.  Impact of ventilator-associated pneumonia on mortality and epidemiological features of patients with secondary peritonitis.

Authors:  María Heredia-Rodríguez; María Teresa Peláez; Inmaculada Fierro; Esther Gómez-Sánchez; Estefanía Gómez-Pesquera; Mario Lorenzo; F Javier Álvarez-González; Juan Bustamante-Munguira; José María Eiros; Jesús F Bermejo-Martin; José I Gómez-Herreras; Eduardo Tamayo
Journal:  Ann Intensive Care       Date:  2016-04-18       Impact factor: 6.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.